肺动脉闭锁的外科治疗和拷贝数变异研究
|
摘要
目的：通过对67例肺动脉闭锁患者外科治疗进行回顾性研究,总结肺动脉闭锁,尤其是合并室间隔缺损肺动脉闭锁患者外科治疗的早期疗效,分析影响术后早期死亡的危险因素。
方法：收集2005年1月-2012年2月,在我院进行手术治疗的肺动脉闭锁患者。患者术前接受心脏彩色多普勒超声等各项检查明确诊断及手术指征,接受手术治疗的67例肺动脉闭锁患者为研究对象。收集该67例肺动脉闭锁患者的住院及随访期间各种临床资料,使用医学统计学方法进行各种数据分析,总结肺动脉闭锁患者外科治疗的早期疗效,评估根治术早期手术死亡的危险因素及预后。
结果：2005年1月-2012年2月中南大学湘雅二医院接受外科治疗的肺动脉闭锁患者共计67例(男35例),其中6例室间隔完整肺动脉闭锁,姑息术患者早期死亡1例,根治术患者早期死亡1例。61例合并室间隔缺损肺动脉闭锁,姑息手术患者无手术早期死亡,根治术患者手术早期死亡3例,随访期间根治术患者死亡2例。姑息手术组患者术前术后氧饱和度及McGoon比值经统计学分析有显著差异。根治手术组患者手术早期死亡单因素分析提示体外循环转流时间,McGoon比值为手术危险因素,Logistic多因素回归分析提示体外循环转流时间为手术危险因素。
结论：肺动脉闭锁患者个体差异大,其外科治疗的早期疗效仍欠佳。姑息手术可显著改善合并室间隔缺损肺动脉闭锁患者的缺氧症状,并且可促进肺血管发育。体外循环时间是合并室间隔缺损肺动脉闭锁(PA-VSD)根治术手术早期死亡的危险因素。
目的：研究拷贝数变异在肺动脉闭锁患者中的发生率及在先天性心脏病遗传致病机制中的作用。
方法：收集2007年6月至2012年2月,湘雅二医院新生儿科,小儿心脏外科及儿科门诊或住院患者,共62例肺动脉闭锁患者样本。抽取患者及父母外周血样本,进行染色体G显带分析。提取外周血gDNA,应用SNP array芯片技术检测拷贝数变异。使用荧光定量PCR验证SNP array芯片分析结果。
结果：所有62例肺动脉闭锁患者的染色体核型分析结果均为正常。使用SNP array芯片在10例肺动脉闭锁患者中共发现7个可能与肺动脉闭锁相关的拷贝数变异位点。其中4例患者CNVs位于22q11.21;2例患者CNVs位于3p26.1-26.3及10p15.1-15.3(此两例患儿为异卵双胞胎姐妹)；1例患者CNVs位于5q13.2；1例患者CNVs位于5q13.3-14.1；1例患者CNVs位于15q26.3；1例患者CNVs位于16p13.3。5q13.2缺失型CNVs,5q14.1重复型CNVs,10p15.1-15.3重复型CNVs,15q26.3重复型CNVs及16p13.3缺失型CNVs均通过Real-Time PCR加以验证,结果与芯片结果一致。
结论：通过SNP array芯片分析,在62例肺动脉闭锁患者中有10例患者携带可能与肺动脉闭锁相关的拷贝数变异,其发生率为16%。除22q11.21缺失型CNVs外,其他6个CNVs均是在先天性心脏病患者中首次报道。通过生物信息学分析,5q13.2缺失型CNVs位点中包含的SMN1及SMN2基因,10p15.1-15.3重复型CNVs位点中包含的Klf6基因,15q26.3重复型CNVs位点中包含的IGF1R基因,16p13.3缺失型CNVs位点中包含的ABCA3及PKD1基因可能是先天性心脏病易感基因。
Objectives:We analyzed the early outcomes of67patients with pulmonary atresia who received surgical treatment by retrospective study. In order to summarize the surgical indication,strategy and risk factors of pulmonary atresia,especially pulmonary atresia with ventricular septal defect.
Methods:67patients were diagnosed as pulmonary atresia by cardiac color Doppler ultrasound,angiocardiography or64row CT cardiovascular angiography.All patients were indicated to surgical treatment,the data of hospitalization and follow-up were collected and analyzed retrospectively by statistical methods.Based on it,we assessed the risk factors and prognosis of surgical repair.
Results:67cases had received surgical treatment from Jan,2005to Feb,2012in Xiangya Second Hospital,including6cases with PA-IVS and61cases with PA-VSD.There are5surgical deaths and2deaths during follow-up.4cases with PA-IVS had received palliative operation,and one died after surgery.2case with PA-IVS had undergone corrective surgery,and one died after surgery.25cases with PA-VSD had underwent palliative operation,including aorto-pulmonary shunt and right ventricle-pulmonary artery connection.The corrective surgery was performed in39cased with PA-VSD,3deaths occurred after surgery.2patients died during follow-up.The patients with PA-VSD who had received palliative operation underwent the significant relief of anoxia and the significant growth of pulmonary artery.In the patients with PA-VSD who received corrective repair,univariate analysis revealed CPB time and McGoon ratio were the risk factors of surgery,but multivariate analysis indicated CPB time was the only risk factor.
Conculusions:The surgical mortality of pulmonary atrsia is unsatisfying.Palliative operation on PA-VSD showed the effects of reducing the anoxia and promoting the growth of pulmonary artery.CPB time is the risk factor of corrective operation on PA-VSD.
Objectives:Studying the incidence of copy number variants in pulmonary atresia and its effects on molecular pathogenesis of congenital heart disease.
Methods:Collecting the blood samples of62patients with pulmonary atresia referred to Xiangya Second Hospital from Jun,2007to Feb,2012.Using the blood samples,we performed chromosome G-banded karyotypes analysis and SNP array.Real-Time PCR was applied to confirm the results of SNP array.
Results:Chromosome G-banded karyotypes analysis showed no aberration in all patients.Using SNP array,we identified7CNVs related with pulmonary atresia in10cases.22q11.21deletion was revealed in4cases.3p26.1-26.3deletion and10p15.1-15.3duplication were found in2cases(this two cases are twins).5q13.2deletion was revealed in1case.5q13.3-14.1duplication was revealed in1case.15q26.3duplication was revealed in1case.16p13.3deletion was revealed in1case. Real-Time PCR confirmed the results of SNP array.
Conculusions:The incidence of CNVs in pulmonary atresia is16%.With the exception of22q11.21deletion,other6CNVs were first reported in congenital heart disease.Based on bioinfonnatics, KLF6,IGF1R,ABCA3,PKD1,SMNland SMN2genes are considered as the "candidate genes" of congenital heart disease.
方法：收集2005年1月-2012年2月,在我院进行手术治疗的肺动脉闭锁患者。患者术前接受心脏彩色多普勒超声等各项检查明确诊断及手术指征,接受手术治疗的67例肺动脉闭锁患者为研究对象。收集该67例肺动脉闭锁患者的住院及随访期间各种临床资料,使用医学统计学方法进行各种数据分析,总结肺动脉闭锁患者外科治疗的早期疗效,评估根治术早期手术死亡的危险因素及预后。
结果：2005年1月-2012年2月中南大学湘雅二医院接受外科治疗的肺动脉闭锁患者共计67例(男35例),其中6例室间隔完整肺动脉闭锁,姑息术患者早期死亡1例,根治术患者早期死亡1例。61例合并室间隔缺损肺动脉闭锁,姑息手术患者无手术早期死亡,根治术患者手术早期死亡3例,随访期间根治术患者死亡2例。姑息手术组患者术前术后氧饱和度及McGoon比值经统计学分析有显著差异。根治手术组患者手术早期死亡单因素分析提示体外循环转流时间,McGoon比值为手术危险因素,Logistic多因素回归分析提示体外循环转流时间为手术危险因素。
结论：肺动脉闭锁患者个体差异大,其外科治疗的早期疗效仍欠佳。姑息手术可显著改善合并室间隔缺损肺动脉闭锁患者的缺氧症状,并且可促进肺血管发育。体外循环时间是合并室间隔缺损肺动脉闭锁(PA-VSD)根治术手术早期死亡的危险因素。
目的：研究拷贝数变异在肺动脉闭锁患者中的发生率及在先天性心脏病遗传致病机制中的作用。
方法：收集2007年6月至2012年2月,湘雅二医院新生儿科,小儿心脏外科及儿科门诊或住院患者,共62例肺动脉闭锁患者样本。抽取患者及父母外周血样本,进行染色体G显带分析。提取外周血gDNA,应用SNP array芯片技术检测拷贝数变异。使用荧光定量PCR验证SNP array芯片分析结果。
结果：所有62例肺动脉闭锁患者的染色体核型分析结果均为正常。使用SNP array芯片在10例肺动脉闭锁患者中共发现7个可能与肺动脉闭锁相关的拷贝数变异位点。其中4例患者CNVs位于22q11.21;2例患者CNVs位于3p26.1-26.3及10p15.1-15.3(此两例患儿为异卵双胞胎姐妹)；1例患者CNVs位于5q13.2；1例患者CNVs位于5q13.3-14.1；1例患者CNVs位于15q26.3；1例患者CNVs位于16p13.3。5q13.2缺失型CNVs,5q14.1重复型CNVs,10p15.1-15.3重复型CNVs,15q26.3重复型CNVs及16p13.3缺失型CNVs均通过Real-Time PCR加以验证,结果与芯片结果一致。
结论：通过SNP array芯片分析,在62例肺动脉闭锁患者中有10例患者携带可能与肺动脉闭锁相关的拷贝数变异,其发生率为16%。除22q11.21缺失型CNVs外,其他6个CNVs均是在先天性心脏病患者中首次报道。通过生物信息学分析,5q13.2缺失型CNVs位点中包含的SMN1及SMN2基因,10p15.1-15.3重复型CNVs位点中包含的Klf6基因,15q26.3重复型CNVs位点中包含的IGF1R基因,16p13.3缺失型CNVs位点中包含的ABCA3及PKD1基因可能是先天性心脏病易感基因。
Objectives:We analyzed the early outcomes of67patients with pulmonary atresia who received surgical treatment by retrospective study. In order to summarize the surgical indication,strategy and risk factors of pulmonary atresia,especially pulmonary atresia with ventricular septal defect.
Methods:67patients were diagnosed as pulmonary atresia by cardiac color Doppler ultrasound,angiocardiography or64row CT cardiovascular angiography.All patients were indicated to surgical treatment,the data of hospitalization and follow-up were collected and analyzed retrospectively by statistical methods.Based on it,we assessed the risk factors and prognosis of surgical repair.
Results:67cases had received surgical treatment from Jan,2005to Feb,2012in Xiangya Second Hospital,including6cases with PA-IVS and61cases with PA-VSD.There are5surgical deaths and2deaths during follow-up.4cases with PA-IVS had received palliative operation,and one died after surgery.2case with PA-IVS had undergone corrective surgery,and one died after surgery.25cases with PA-VSD had underwent palliative operation,including aorto-pulmonary shunt and right ventricle-pulmonary artery connection.The corrective surgery was performed in39cased with PA-VSD,3deaths occurred after surgery.2patients died during follow-up.The patients with PA-VSD who had received palliative operation underwent the significant relief of anoxia and the significant growth of pulmonary artery.In the patients with PA-VSD who received corrective repair,univariate analysis revealed CPB time and McGoon ratio were the risk factors of surgery,but multivariate analysis indicated CPB time was the only risk factor.
Conculusions:The surgical mortality of pulmonary atrsia is unsatisfying.Palliative operation on PA-VSD showed the effects of reducing the anoxia and promoting the growth of pulmonary artery.CPB time is the risk factor of corrective operation on PA-VSD.
Objectives:Studying the incidence of copy number variants in pulmonary atresia and its effects on molecular pathogenesis of congenital heart disease.
Methods:Collecting the blood samples of62patients with pulmonary atresia referred to Xiangya Second Hospital from Jun,2007to Feb,2012.Using the blood samples,we performed chromosome G-banded karyotypes analysis and SNP array.Real-Time PCR was applied to confirm the results of SNP array.
Results:Chromosome G-banded karyotypes analysis showed no aberration in all patients.Using SNP array,we identified7CNVs related with pulmonary atresia in10cases.22q11.21deletion was revealed in4cases.3p26.1-26.3deletion and10p15.1-15.3duplication were found in2cases(this two cases are twins).5q13.2deletion was revealed in1case.5q13.3-14.1duplication was revealed in1case.15q26.3duplication was revealed in1case.16p13.3deletion was revealed in1case. Real-Time PCR confirmed the results of SNP array.
Conculusions:The incidence of CNVs in pulmonary atresia is16%.With the exception of22q11.21deletion,other6CNVs were first reported in congenital heart disease.Based on bioinfonnatics, KLF6,IGF1R,ABCA3,PKD1,SMNland SMN2genes are considered as the "candidate genes" of congenital heart disease.
引文
[1]Rosamond W, Flegal K, Friday G et al:Heart disease and stroke statistics--2007 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation.2007; e69-171.
[2]Leonard H, Derrick G, O'Sullivan J,et al.Natural and unnatural history of pulmonary atresia.Heart.2000,84(5):499-503.
[3]Tchervenkov CI, Roy N. Congenital Heart Surgery Nomenclature and Database Project:pulmonary atresia--ventricular septal defect.Ann Thorac Surg.2000;69(4 Suppl):S97-105.
[4]Agnoletti G, Piechaud JF, Bonhoeffer P,et al. Perforation of the atretic pulmonary valve:Long-term follow-up. J Am Coll Cardiol.2003;41(8):1399-403.
[5]Alwi M, Geetha K, Bilkis AA, et al. Pulmonary atresia with intact ventricular septum:percutaneous radiofrequency-assisted valvotomy and balloon dilation versus surgical valvotomy and Blalock-Taussig shunt.J Am Coll Cardiol. 2000;35:468-76.
[6]陈纲,刘芳,吴琳,等.经右室穿刺肺动脉瓣球囊扩张治疗室间隔完整型肺动脉闭锁.中华小儿外科杂志,2011,32(4)：262-4.
[7]董卫,张海波.室间隔完整型肺动脉闭锁的镶嵌治疗.上海交通大学学报(医学版),2011,31(9)：1291-4.
[8]胡盛寿,李守军,张浩,等.“杂交”技术治疗新生儿期室间隔完整的肺动脉闭锁.中华胸心血管外科杂志,2006,22(6)：376-7.
[9]Marasini M, Gorrieri PF, Tuo G,et al.Long-term results of catheter-based treatment of pulmonary atresia and intact ventricular septum. Heart.2009;95(18):1520-4.
[10]Azakie A, McCrindle BW, Van Arsdell G,et al. Extracardiac conduit versus lateral tunnel cavopulmonary connections at a single institution:impact on outcomes. J Thorac Cardiovasc Surg.2001; 122(6):1219-28.
[11]梅举,张宝仁,杨小龙,等.非体外循环下改良全腔静脉-肺动脉连接术.中华胸心血管外科杂志,2002,18(6)：325-7.
[12]许建屏,罗新锦,吴清玉,等.非体外循环下全腔静脉肺动脉连接术的临床 应用.中华胸心血管外科杂志,2004,20(2)：84-6.
[13]Dyamenahalli U, McCrindle BW, McDonald C,et al. Pulmonary atresia with intact ventricular septum:management of, and outcomes for, a cohort of 210 consecutive patients. Cardiol Young 2004;14:299-308.\
[14]Bautista-Hernandez V, Hasan BS, Harrild DM,et al. Late pulmonary valve replacement in patients with pulmonary atresia and intact ventricular septum:a case-matched study. Ann Thorac Surg.2011;91(2):555-60.
[15]Shinkawa T, Yamagishi M, Shuntoh K,et al. One-stage definitive repair of pulmonary atresia with intact ventricular septum and hypoplastic right ventricle.J Thorac Cardiovasc Surg.2005;130(4):1207-8.
[16]J Stark,M de Leval,VT Tsang.Surgery for Congenital Heart Defects. Wiley-Blackwell.2006,pp411-22.
[17]Jonas RA,Tetralogy of Fallot with pulmonary atresia,in Comprehensive surgical management of congenital heart disease.R.A. Jonas,Edition.2004.p440-56.
[18]Reddy VM, Liddicoat JR, Hanley FL. Midline one-stage complete unifocalization and repair of pulmonary atresia with ventricular septal defect and major aortapulmonary collaterals. J Thorac Cardiovasc Surg.1995; 109:832-845.
[19]d'Udekem Y, Alphonso N, N(?)rgaard MA,et al. Pulmonary atresia with ventricular septal defects and major aortopulmonary collateral arteries:unifocalization brings no long-term benefits. J Thorac Cardiovasc Surg.2005; 130(6):1496-502.
[20]Brizard CP, Liava'a M, d'Udekem Y. Pulmonary atresia, VSD and Mapcas:repair without unifocalization. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009:139-44.
[21]Duncan BW, Mee RB, Prieto LR,et al. Staged repair of tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg.2003;126(3):694-702.
[22]Mumtaz MA, Rosenthal G, Qureshi A,et al. Melbourne shunt promotes growth of diminutive central pulmonary arteries in patients with pulmonary atresia, ventricular septal defect, and systemic-to-pulmonary collateral arteries.Ann Thorac Surg.2008; 85(6):2079-83.
[23]Bradley SM, Erdem CC, Hsia TY,et al. Right ventricle-to-pulmonary artery shunt: alternative palliation in infants with inadequate pulmonary blood flow prior to two-ventricle repair. Ann Thorac Surg.2008;86(1):183-8.
[24]邓喜成.先天性肺动脉闭锁合并室间隔缺损的回顾性临床研究与全基因组拷贝数变异分析.长沙：中南大学,2010.
[25]郑景浩,徐志伟,苏肇伉,等.小儿肺动脉闭锁伴室间隔缺损右室流出道重建方法.中华胸心血管外科杂志,2005,21(5)：257-9.
[26]Reddy VM, McElhinney DB, Amin Z,et al. Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries:experience with 85 patients. Circulation.2000; 101:1826-1832.
[27]Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart disease.The genetic-environmental interaction.Circulation.1968,38:604-617.
[28]Sebat J, Lakshmi B, Troge J,et al. Large-scale copy number polymorphism in the human genome.Science.2004;305(5683):525-8.
[29]Redon R, Ishikawa S, Fitch KR,et al. Global variation in copy number in the human genome. Nature.2006;444(7118):444-54.
[30]杜仁骞,金力,张锋.基因组拷贝数变异及其突变机理与人类疾病.遗传.2011,33(8)：857-869.
[31]Drake JA, et al. Conserved noncoding sequences are selectively constrained and not mutation cold spots. Nat Genet.2006;38:223-7.
[32]Freeman JL, Perry GH, Feuk L,et al. Copy number variation:new insights in genome diversity.Genome Res.2006;16(8):949-61. Epub 2006 Jun 29.
[33]Singleton AB, Farrer M, Johnson J,et al.alpha-Synuclein locus triplication causes Parkinson's disease.Science.2003;302(5646):841.
[34]Cooper GM, Coe BP, Girirajan S,et al. A copy number variation morbidity map of developmental delay. Nat Genet.2011;43(9):838-46.
[35]Sebat, J., Lakshmi, B., et al. Strong association of de novo copy number mutations with autism. Science.2007; 316:445-449.
[36]Cook EH, et al. Copy-number variations associated with neuropsychiatric conditions.Nature,2008; 455(7215):919-923.
[37]Carter NP. Methods and strategies for analyzing copy number variation using DNA microarrays.Nat Genet.2007;39(7 Suppl):S16-21.
[38]Pierpont ME, Basson CT, Benson DW, et al.Genetic basis for congenital heart defects:current knowledge:a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on cardiovascular disease in the young. Circulation.2007; 115:3015-3038.
[39]Garg V.Insights into the genetic basis of congenital heart disease. Cell Mol Life Sci.2006; 63:1141-1148.
[40]Lammer E, Chak J, Iovannisci D, et al. Chromosomal abnormalities among children born with conotruncal cardiac defects. Birth Defects Res.2009;85:30-35.
[41]Goldmuntz E, Clark BJ, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol.1998; 32:492-498.
[42]Ensenauer RE,Adeyinka A,Flynn HC,et al.Microduplication 22q11.2,an emerging syndrome:clinical, cytogenic, and molecular analysis of thirteen patients. Hum Genet.2003;73:1027-1040.
[43]Vissers LE, van Ravenswaaij CM, Admiraal R,et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.Nat Genet.2004;36(9):955-7.
[44]Janssen N, Bergman JE, Swertz MA,et al. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat.2012 Mar 27. [Epub ahead of print]
[45]Greenway SC, Pereira AC, Lin JC, et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot.Nat Genet.2009;41: 931-935.
[46]Database of Genomic Variants, http://proiects.tcag.ca/variation/
[47]Pinto D, Darvishi K, Shi X,et al. Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechnol.2011;29(6):512-20.
[48]Brunet A,Armengol L,Heine D,et al.BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1. BMC Med Genet.2009;10:144.
[49]Nakamura E,Makita Y,Okamoto T,et al.5.78 Mb terminal deletion of chromosome 15q in a girl, evaluation of NR2F2 as candidate gene for congenital heart defects. Eur J Med Genet.2011;54(3):354-6.
[50]Burn J and Goodship J (1996) Congenital heart disease. In Rimoin DL, Conner JM, Pyeritz RE and Emery AEH(eds),Emery and Rimoin's Principles and Practice of Medical Genetics.Churchill Livingstone, New York, Vol.1, pp.767-803.
[51]Jerome LA, Papaioannou VE. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbxl. Nat Genet.2001;27:286-91.
[52]Lindsay EA, Vitelli F, Su H,et al. Tbxl haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature.2001;410:97-101.
[53]Merscher S, Funke B, Epstein JA,et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell.2001;104:619-29.
[54]Momma K. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome.Am J Cardiol.2010;105(11):1617-24.
[55]van Engelen K, Topf A, Keavney BD,et al.22q11.2 Deletion Syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia.Heart.2010;96(8):621-4.
[56]Lee Y, Song A, Baker R, et al. Jumonji, a nuclear protein that is necessary for normal heart development. Circ Res.2000;86:932-938.
[57]Ou Z, Berg H, Yonath VB, et al.Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes.Genet Med.2008;4:267-77.
[58]Ensenauer RE,Adeyinka A,Flynn HC.et al.Microduplication 22q11.2,an emerging syndrome:clinical,cytogenic, and molecular analysis of thirteen patients.Hum Genet.2003;73:1027-1040.
[591 Zweier C, Sticht H, Aydin-Yaylagul I, et al. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.Am J Hum Genet.2007; 80:510-517.
[60]Fernandez TV, Garcia-Gonzalez IJ, Mason CE,et al. Molecular characterization of a patient with 3p deletion syndrome and a review of the literature. Am J Med Genet A,2008 Nov 1;146A(21):2746-52.
[61]Guilherme RS, Bragagnolo S, Pellegrino R,et al. Clinical, cytogenetic and molecular study in a case of r(3) with 3p deletion and review of the literature. Cytogenet Genome Res.2011;134(4):325-30.
[62]Fernandez T, Morgan T, Davis N,et al. Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am J Hum Genet.2004;74(6):1286-93.
[63]Saunders IW,Ross J,Macrae F,et al.Evidence of linkage to chromosomes 10p15.3-p15.1,14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families.Eur J Hum Genet.2012;20(1):91-6.
[64]Leuraud P,Aguirre-Cruz L,Hoang-Xuan K,et al.Telomerase reactivation in malignant gliomas and loss of heterozygosity on 10p15.1.Neurology.2003;60 (11):1820-2.
[65]Firth HV,Richards SM,Bevan AP,Clayton S, Corpas M, Rajan D, Van VS,Moreau Y, Pettett RM, Carter NP. DECIPHER:Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources.Am J Hum Genet.2009;84:524-533.
[66]Tremblay N, Yang SW, Hitz MP,et al.Familial ventricular aneurysms and septal defects map to chromosome 10p15. Eur Heart J.2011;32(5):568-73.
[67]DiFeo A,Martignetti JA,Narla GThe role of KLF6 and its splice variants in cancer therapy. Drug Resist Updat.2009;12(1-2):1-7.
[68]Spinola M, Leoni VP, Galvan A, et al. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene.Cancer Lett. 2007;251(2):311-6.
[69]Gehrau RC, D'Astolfo DS, Dumur CI,et al. Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.PLoS One.2010;28;5(1):e8929.
[70]Zhang Q. Tan XP, Yuan YS,et al. Decreased expression of KLF6 and its significance in gastric carcinoma.Med Oncol.2010;27(4):1295-302.
[71]De Stefano D, Li P, Xiang B,et al.Pulmonary atresia with intact ventricular septum (PA-IVS) in monozygotic twins.Am J Med Genet A.2008;15;146A(4): 525-8.
[72]Pinson L, Perrin A, Plouzennec C,et al. Detection of an unexpected subtelomeric 15q26.2-> qter deletion in a little girl:clinical and cytogenetic studies.Am J Med Genet A.2005;138A(2):160-5.
[73]Russo VC,Gluckman PD,Feldman EL,et al.The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev.2005;26(7):916-43.
[74]Inagaki K,Tiulpakov A,Rubtsov P,et al.A familial insulin-like growth factor-I receptor mutant leads to short stature:clinical and biochemical characterization.J Clin Endocrinol Metab.2007;92(4):1542-8.
[75]Abuzzahab MJ, Schneider A, Goddard A,et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation.N Engl J Med.2003;349(23):2211-22.
[76]Liu JP, Baker J, Perkins AS, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr).Cell. 1993;75(1):59-72.
[77]Davidsson J, Collin A, Bjorkhem G,et al. Array based characterization of a terminal deletion involving chromosome subband 15q26.2:an emerging syndrome associated with growth retardation, cardiac defects and developmental delay. BMC Med Genet.2008;14;9:2.
[78]Ester WA, van Duyvenvoorde HA, de Wit CC,et al. Two short children born small for gestational age with insulin-like growth factor 1 receptor haploinsufficiency illustrate the heterogeneity of its phenotype.J Clin Endocrinol Metab.2009;94(12):4717-27.
[79]Poot M, Eleveld MJ, van't Slot R,et al. Proportional growth failure and oculocutaneous albinism in a girl with a 6.87 Mb deletion of region 15q26.2--> qter.Eur J Med Genet.2007;50(6):432-40.
[80]Rujirabanjerd S, Suwannarat W, Sripo T,et al. De novo subtelomeric deletion of 15q associated with satellite translocation in a child with developmental delay and severe growth retardation.Am J Med Genet A.2007;143(3):271-6.
[81]Rump P, Dijkhuizen T, Sikkema-Raddatz B,et al.Drayer's syndrome of mental retardation, microcephaly, short stature and absent phalanges is caused by a recurrent deletion of chromosome 15(q26.2-->qter).Clin Genet.2008;74(5):455-62.
[82]Pereira FA, Qiu Y,Zhou G, et al. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development.Genes Dev.1999;13(8):1037-49.
[83]Gruber PJ, Epstein JA. Development gone awry:congenital heart disease.Circ Res.2004;94(3):273-83.
[84]Schlueter PJ,Royer T Farah MH,et al.Gene duplication and functional divergence of the zebrafish insulin-like growth factor 1 receptors.FASEB J.2006;20(8):1230-2.
[85]Schlueter PJ, Peng G, Westerfield M,et al. Insulin-like growth factor signaling regulates zebrafish embryonic growth and development by promoting cell survival and cell cycle progression.Cell Death Differ.2007;14(6):1095-105.
[86]Hennekam RC.Rubinstein-Taybi syndrome.Eur J Hum Genet.2006;14(9):981-5.
[87]Rubinstein JH, Taybi H.1963. Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child.105:588-608.
[88]Yamano G, Funahashi H, Kawanami O,et al. ABCA3 is a lamellar body membrane protein in human lung alveolar type Ⅱ cells.FEBS Lett.2001;508(2): 221-5.
[89]Hallman M. Lung surfactant, respiratory failure, and genes.N Engl J Med.2004; 350:1278-80.
[90]Nagata K, Yamamoto A, Ban N,et al. Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles.Biochem Biophys Res Commun.2004;324(l):262-8.
[91]Shulenin S, Nogee LM, Annilo T, et al. ABC A3 genemutations in newborns with fatal surfactant deficiency. N Engl J Med.2004;350:1296-303.
[92]Garmany TH, Wambach JA, Heins HB,et al. Population and disease-based prevalence of the common mutations associated with surfactant deficiency.Pediatr Res.2008;63(6):645-9.
[93]Matsumura Y, Ban N. Ueda K,et al. Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fata1 surfactant deficiency.J Biol Chem.2006;281(45):34503-14.
[94]江林,杜立中ABCA3基因突变在新生儿呼吸窘迫综合征的研究进展.国际儿科学杂志.2009；36(5)：474-6.
[95]Cuello F, Bardswell SC, Haworth RS,et al. Protein kinase D selectively targets cardiac troponin I and regulates myofilament Ca2+ sensitivity in ventricular myocytes. Circ Res.2007;100(6):864-73.
[96]Fielitz J, Kim MS, Shelton JM,et al. Requirement of protein kinase Dl for pathological cardiac remodeling.Proc Natl Acad Sci U S A .2008;105(8):3059-63.
[97]Li C, Li J, Cai X,et al. Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors.J Biol Chem.2011;286(47):40782-91.
[98]Benson DW, Silberback GM, Kavanaugh-McHugh A, et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest.1999;104:1567-1573.
[99]Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation.2001;104:2565-2568.
[100]Garg V, Kathiriya IS, Barnes R, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature.2003; 424:443-447.
[101]Lorson CL, Hahnen E, Androphy EJ,et al. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A.1999;96(11):6307-11.
[102]Cartegni L, Krainer AR. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet.2002;30(4):377-84.
[103]Heier CR, DiDonato CJ.Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo. Hum Mol Genet.2009; 18(7):1310-22.
[104]Shababi M, Habibi J, Yang HT, et al. Cardiac defects contribute to the pathology of spinal muscular atrophy models.Hum Mol Genet.2010;19(20):4059-71.
[105]Lefebvre S, Burglen L, Reboullet S,et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell.1995;80:155-65.
[106]Jedrzejowska M, Milewski M, Zimowski J,et al. Phenotype modifiers of spinal muscular atrophy:the number of SMN2 gene copies, deletion in the NAEP gene and probably gender influence the course of the disease. Acta Biochim. 2009;56:103-8.
[107]Mulleners WM, van Ravenswaay CM, Gabreels FJ,et al. Spinal muscular atrophy combined with congenital heart disease:a report of two cases. Neuropediatrics.1996;27:333-4.
[108]Rudnik-Schoneborn S, Heller R, Berg C, et al.Congenital heart disease is a feature of severe infantile spinal muscular atrophy. Med Genet.2008;45:635-8.
[109]Moller P, Moe N, Saugstad OD, et al. Spinal muscular atrophy type i combined with atrial septal defect in three sibs. Clin Genet.1990;38:81-3.
[110]Bevan AK,Hutchinson KR,Foust KD, et al.Early heart failure in the SMN{delta} 7 model of spinalmuscular atrophy and correction by postnatal scAAV9-smn delivery. Hum Mol Genet.2010;19(20):3895-905.
[111]Heier CR, Satta R, Lutz C,et al. Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice.Hum Mol Genet.2010;19(20):3906-18.
[112]Shababi M, Habibi J, Ma L,et al. Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy. J Mol Cell Cardiol.2012. Epub ahead of print.
[113]Giugliani R, Harmatz P, Wraith JE. Management guidelines for mucopoly-saccharidosis VI. Pediatrics.2007;120(2):405-18. Review.
[114]Gottwald I, Hughes J, Stewart F,et al. Attenuated mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) due to homozygosity for the p.Y210C mutation in the ARSB gene.Mol Genet Metab.2011;103(3):300-2.
[115]Marwick TH,Bastian B,Hughes CF,et al. Mitral stenosis in the Maroteaux-Lamy syndrome:a treatable cause of dyspnoea.Postgrad Med J.1992;68(798):287-8.
[116]Tan CT, Schaff HV, Miller FA Jr,et al. Valvular heart disease in four patients with Maroteaux-Lamy syndrome.Circulation.1992;85(1):188-95.
[117]Wilson CS, Mankin HT, Pluth JR. Aortic stenosis and mucopolysaccharidosis. Ann Intern Med.1980;92(4):496-8.
[118]Swiedler SJ,Beck MJBajbouj M,et al.Threshold effect of urinary glycosamino-glycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).Am J Med Genet A.2005;134A(2):144-50.
[119]Azevedo AC, Schwartz IV, Kalakun L,et al.Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI. Clin Genet.2004;66(3):208-13.
[120]Jurecka A, Golda A, Opoka-Winiarska V,et al. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype.Mol Genet Metab.2011;104(4):695-9.
[1]Leonard H, Derrick G, O'Sullivan J,et al. Natural and unnatural history of pulmonary atresia.Heart.2000,84(5):499-503.
[2]Mavroudis C,Backer CL.Pediatric cardiac surgery,ed 3, Singapore,2004, Elsevier.
[3]Kutsche LM, Van Mierop LHS. Pulmonary atresia with and without ventricular septal defect:a different etiology and pathogenesis for the atresia in the 2 types? Am J Cardiol.1983;51:932-5.
[4]Stuckey D,Bowdler JD,Reye RD.Absent sixth aortic arch:a form of pulmonary atresia.Br Heart J.1968,30(2):258-64.
[5]汪曾炜,刘维永,张宝仁。心脏外科学,第一版,2003年,人民军医出版社。
[6]Marino B, Calabro R, Gagliardi MG, et al. Patterns of pulmonary arterial anatomy and blood supply in complex congenital heart disease with pulmonary atresia. J Thorac Cardiovasc Surg.1987,94(4):518-20.
[7]Boshoff D, Gewillig M.A review of the options for treatment of major aortopulmonary collateral arteries in the setting of tetralogy of Fallot with pulmonary atresia. Cardiol Young.2006,16(3):212-20.
[8]Reddy VM, Liddicoat JR, Hanley FL. Midline one-stage complete unifocalization and repair of pulmonary atresia with ventricular septal defect and major aortapulmonary collaterals. J Thorac Cardiovasc Surg.1995; 109:832-845.
[9]Liao P,Edwards WD, Julsrud PR,et al. Pulmonary blood supply in patients with pulmonary atresia and ventricular septal defect.J Am Coll Cardiol.1985;6:1343-1350.
[10]Amin Z, McElhinney DB, Reddy M,et al. Coronary to pulmonary artery collaterals in patients with pulmonary atresia and ventricular septal defect. Ann Thorac Surg.2000;70:119-123.
[11]Thiene G, Frescura C, Bini RM. et al. Histology of pulmonary arterial supply in pulmonary atresia with ventricular septal defect. Circulation.1979;60:1066-1074.
[12]McElhinney DB, Reddy VM, Hanley FL. Tetralogy of Fallot with major aortopulmonary collaterals:early total repair. Pediatr Cardiol.1998;19:289-296.
[13]Permut LC, Laks H, Aharon A. Surgical management of pulmonary atresia with ventricular septal defect and multiple aortopulmonary collaterals.Isr J Med Sci. 1994; 30:215-224.
[14]Freedom RM, Rabinovitch M. Pulmonary atresia and ventricular septal defect. In: Freedom RM, Benson LN, Smallhorn JF (eds).Neonatal Heart Disease. Springer-Verlag, London,1992,pp229-256.
[15]Edwards JE, McGoon DC. Absence of anatomic origin from heart of pulmonary arterial supply. Circulation.1973;47:393-8.
[16]McGoon DC, Baird DK, Davis GD. Surgical management of large bronchial collateral arteries with pulmonary stenosis or atresia. Circulation.1975;52:109-18.
[17]Rabinovitch M, Herrera-deLeon V, Castaneda AR,et al. Growth and development of the pulmonary vascular bed in patients with tetralogy of Fallot with or without pulmonary atresia. Circulation.1981;64:1234-49.
[18]Bull C, de Leval MR, Mercanti C,et al. Pulmonary atresia and intact ventricular septum:a revised classification. Circulation.1982;66:266-72.
[19]Mavroudis C,Backer CL.Pediatric Cardiac Surgery.Elsevier, Singapore,2004, pp324-339.
[20]Gittenberger-de Groot AC, Sauer U, Bindl L,et al. Competition of coronary arteries and ventriculo-coronary arterial communications in pulmonary atresia with intact ventricular septum. Int J Cardiol.1988;18(2):243-58.
[21]Barbero-Marcial M, Jatene AD. Surgical management of the anomalies of the pulmonary arteries in the tetralogy of Fallot with pulmonary atresia. Semin Thorac Cardiovasc Surg.1990; 2:93-107.
[22]Tchervenkov CI, Roy N. Congenital Heart Surgery Nomenclature and Database Project:pulmonary atresia--ventricular septal defect.Ann Thorac Surg.2000;69(4 Suppl):S97-105.
[23]J Stark,M de Leval,VT Tsang. Surgery for Congenital Heart Defects. Wiley-Blackwell.2006,pp411-22.
[24]Lofland GK.Progress in Pediatric Cardiology.Elsevier.2009, pp55-59.
[25]Van Arsdell G, Yun TJ. An apology for primary repair of tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu.2005;128-31.
[26]Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot in the neonate:results in the modern era.Ann Surg.2000;232:508-14.
[27]Hennein HA, Mosca RS, Urcelay G.et al.Intermediate results after complete repair of tetralogy of Fallot in neonates. J Thorac Cardiovasc Surg.1995;109:332-44.
[28]Kwak JG, Lee CH, Lee C,et al. Surgical management of pulmonary atresia with ventricular septal defect:early total correction versus shunt. Ann Thorac Surg. 2011;91(6):1928-34.
[29]Lillehei CW,Cohen M,Warden HE,et al.Direct vision intracardiac surgical correction of the tetralogy of Fallot, pentalogy of Fallot, and pulmonary atresia defects; report of first ten cases. Ann Surg.l955;142(3):418-42.
[30]Bowman FO Jr, Malm JR, Hayes CJ,et al.Pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg.1971;61:85-95.
[31]Haworth SG,Rees PG, Taylor JF,et al. Pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. Effect of systemic pulmonary anastomosis. Br Heart J.1981;45:133-41.
[32]Nakanishi T. Balloon dilation and stent implantation for vascular stenosis. Pediatr Int.2001;43:548-52.
[33]Holzer R, Chrisolm J, Hill S, et al. "Hybrid" stent delivery in the pulmonary circulation. J Invasive Cardiol.2008;20:592-8.
[34]Brown SC, Eyskens B, Mertens L,et al. Percutaneous treatment of stenosed major aortopulmonary collaterals with balloon dilatation and stenting:what can be achieved? Heart.1998;79:24-8.
[35]Cleuziou J, Schreiber C, Eicken A,et al. Predictors for biventricular repair in pulmonary atresia with intact ventricular septum.Thorac Cardiovasc Surg.2010; 58:339-44.
[36]Foker JE, Setty SP, Berry J,et al. Treatment of right ventricle to coronary artery connections in infants with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg.2008; 136:749-56.
[37]Akagi T, Benson LN, Williams WG,et al. Ventriculocoronary arterial connections in pulmonary atresia with intact ventricular septum, and their influences on ventricular performance and clinical course. Am J Cardiol.1993;72: 586-90.
[38]Yoshimura N, Yamaguchi M. Surgical strategy for pulmonary atresia with intact ventricular septum:initial management and definitive surgery. Gen Thorac Cardiovasc Surg.2009;57(7):338-46.
[39]Giglia TM, Jenkins KJ, Matitiau A,et al. Influence of right heart size on outcome in pulmonary atresia with intact ventricular septum.Circulation.1993;88:2248-56.
[40]Shaddy RE, Sturtevant JE, Judd VE, et al. Right ventricular growth after transventricular pulmonary valvotomy and central aortopulmonary shunt for pulmonary atresia and intact ventricular septum.Circulation.1990;82(5 Suppl): Ⅳ157-63.
[41]Lewis AB, Wells W, Lindesmith GG. Right ventricular growth potential in neonates with pulmonary atresia and intact ventricular septum.J Thorac Cardiovasc Surg.1986;91 (6):835-40.
[42]Shinkawa T, Yamagishi M, Shuntoh K,et al. One-stage definitive repair of pulmonary atresia with intact ventricular septum and hypoplastic right ventricle. J Thorac Cardiovasc Surg.2005;130(4):1207-8.
[43]McCaffrey FM, Leatherbury L, Moore HV. Pulmonary atresia and intact ventricular septum:defi nitive repair in the neonatal period. J Thorac Cardiovasc Surg.1991;102:617-23.
[44]Rychik J, Levy H, Gaynor JW,et al.Outcome after operations for pulmonary atresia with intact ventricular septum.J Thorac Cardiovasc Surg.1998;116:924-31.
[45]Yoshimura N, Yamaguchi M, Ohashi H,et al. Pulmonary atresia with intact ventricular septum:strategy based on right ventricular morphology. J Thorac Cardiovasc Surg.2003;126(5):1417-26.
[46]Bull C, Kostelka M, Sorensen K,et al. Outcome measures for the neonatal management of pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg.1994; 107:359-66.
[47]Hanley FL, Sade RM, Blackstone EH,et al.Outcomes in neonatal pulmonary atresia with intact ventricular septum. A multiinstitutional study. J Thorac Cardiovasc Surg.1993; 105:406-27.
[48]Gentles TL, Colan SD, Giglia TM,et al. Right ventricular decompression and left ventricular function in pulmonary atresia with intact ventricular septum:the influence of less extensive coronary anomalies. Circulation.1993;88:183-8.
[49]Jahangiri M, Zurakowski D, Bichell D,et al. Improved results with selective management in pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg.1999; 118:1046-55.
[50]Sano S, Ishino K, Kawada M,et al. Staged biventricular repair of pulmonary atresia or stenosis with intact ventricular septum. Ann Thorac Surg.2000;70:1501-6.
[51]Hawkins JA, Thorne JK, Boucek MM, et al. Early and late results in pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg.1990:100:492-7.
[52]Shaddy RE, Sturtevant JE, Judd VE,et al. Right ventricular growth after transventricular pulmonary valvotomy and central aortopulmonary shunt for pulmonary atresia and intact ventricular septum.Circulation.1990;82(IV):157-63.
[53]Joshi SV,Brawn WJ,Mee RBB.Pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg.1986;91:192-9.
[54]Hirata Y, Chen JM, Quaegebeur JM,et al. Pulmonary atresia with intact ventricular septum:limitations of catheter-based intervention. Ann Thorac Surg. 2007;84:574-80.
[55]Ovaert C, Qureshi SA, Rosenthal E,et al.Growth of the right ventricle after transcatheter pulmonary valvotomy in neonates and infants with pulmonary atresia and intact ventricular septum.J Thorac Cardiovasc Surg.1998; 115:1055-62.
[56]McLean KM, Pearl JM. Pulmonary atresia with intact ventricular septum:initial management. Ann Thorac Surg.2006;82:2214-20.
[57]Alwi M, Geetha K, Bilkis AA, et al. Pulmonary atresia with intact ventricular septum:percutaneous radiofrequency-assisted valvotomy and balloon dilation versus surgical valvotomy and Blalock-Taussig shunt..J Am Coll Cardiol.2000;35: 468-76.
[58]Zhang H, Li SJ, Li YQ,et al. Hybrid procedure for the neonatal management of pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg.2007; 133(6):1654-6.
[59]Coles JG, Freedom RM, Lightfoot NE,et al. Long-term results in neonates with pulmonary atresia and intact ventricular septum.Ann Thorac Surg.1989;47:213-7.
[60]Reddy VM,Ungerleider RM,Hanley FL:Pulmonary valve atrsia with intact ventricular septum.In Garson AG Jr,Brickner JT,Fischer DJ,et al,eds:The science and practice of pediatric cardiology,ed 2,Baltimore,1998,Williams& Wilkins.
[61]Yamaguchi M, Ohashi H, Oshima Y,et al. Transpulmonary open-valvotorny and later defi nitive repair for pulmonary atresia with intact ventricular septum. In: Proceedings of the 2nd World Congress of Pediatric Cardiology and Cardiac Surgery,1998,pp798-800.
[62]McGoon DC, Baird DK, Davis GD. Surgical management of large bronchial collateral arteries with pulmonary stenosis or atresia.Circulation.1975;52:109-118.
[63]Nakata S, Imai Y, Takanashi Y,et al.A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. J Thorac Cardiovasc Surg. 1984;88:610-619.
[64]Pigula FA, Khalil PN, Mayer JE,et al. Repair of tetralogy of Fallot in neonates and young infants. Circulation.1999;100:Ⅱ157-61.
[65]Kwak JG, Lee CH, Lee C,et al. Surgical management of pulmonary atresia with ventricular septal defect:early total correction versus shunt. Ann Thorac Surg. 2011;91(6):1928-34.
[66]Watterson KG, Wilkinson JL, Karl TR,et al. Very small pulmonary arteries: central end-to-side shunt.Ann Thorac Surg.1991;52:1132-7,
[67]Duncan BW, Mee RB, Prieto LR,et al. Staged repair of tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg.2003; 126:694-702.
[68]Puga FJ, Leoni FE, Julsrud PR,et al. Complete repair of pulmonary atresia, ventricular septal defect and severe peripheral arborization abnormalities of central pulmonary arteries. J Thorac Cardiovasc Surg.l989;98:1018-1029.
[69]Iyer KS, Mee RB.Staged repair of pulmonary atresia with ventricular septal defect and major systemic to pulmonary artery collaterals.Ann Thorac Surg.1991; 51:65-72.
[70]Marelli JA, Perloff KJ, Child SJ,et al. Pulmonary atresia with ventricular septal defect in adults.Circulation.1994;89:243-251.
[71]Reddy VM, McElhinney DB, Amin Z,et al. Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries:experience with 85 patients.Circulation.2000; 101:1826-1832.
[72]Lofland GK. The management of pulmonary atresia, ventricular septal defect, and multiple aorto-pulmonary collateral arteries by definitive single stage repair in early infancy. Eur J Cardiothorac Surg.2000;18:480-486.
[73]Abella RF, De La Torre T, Mastropietro G,et al. Primary repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals:a useful approach. J Thorac Cardiovasc Surg.2004; 127:193-202.
[74]Puga FJ, Leoni FE, Julsrud PR,et al. Complete repair of pulmonary atresia, ventricular septal defect, and severe peripheral arborization abnormalities of the central pulmonary arteries.Experience with preliminary unifocalization procedures in 38 patients. J Thorac Cardiovasc Surg.l989;98(6):1018-28.
[75]Reddy VM, Petrossian E, McElhinney DB et al. One-stage complete unifocalization in infants:when should the ventricular septal defect be closed? J Thorac Cardiovasc Surg.1997;113:858-68.
[76]Carotti A, Di Donato RM, Squitieri C,et al. Total repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals:an integrated approach. J Thorac Cardiovasc Surg.1998;116:914-923.
[77]Mei J, Ding FB, Zhu JQ,et al.A novel two-stage complete repair method for pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. Chin Med J (Engl).2010;123(3):259-64.
[78]Murthy KS, Krishnanaik S, Coelho R,et al. Median sternotomy single stage complete unifocalization for pulmonary atresia, major aorto-pulmonary collateral arteries and VSD-early experience.Eur J Cardiothorac Surg.l999;16(1):21-5.
[79]Murthy KS, Rao SG, Naik SK,et al. Evolving surgical management for ventricular septal defect, pulmonary atresia, and major aortopulmonary collateral arteries. Ann Thorac Surg.l 999;67(3):760-4.
[80]Griselli M, McGuirk SP, Winlaw DS,et al.The influence of pulmonary artery morphology on the results of operations for major aortopulmonary collateral arteries and complex congenital heart defects.J Thorac Cardiovasc Surg.2004;127: 251-258.
[81]d'Udekem Y, Alphonso N, N(?)rgaard MA,et al.Pulmonary atresia with ventricular septal defects and major aortopulmonary collateral arteries:unifocalization brings no long-term benefits.J Thorac Cardiovasc Surg.2005;130(6):1496-502.
[82]Brizard CP, Liava'a M, d'Udekem Y.Pulmonary atresia,VSD and Mapcas:repair without unifocalization.Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009; 139-44.
[83]Liava'a M, Brizard CP, Konstantinov IE,et al. Pulmonary atresia, ventricular septal defect, and major aortopulmonary collaterals:neonatal pulmonary artery rehabilitation without unifocalization. Ann Thorac Surg.2012;93(1):185-91.
[84]Davies B, Mussa S, Davies P,et al.Unifocalization of major aortopulmonary collateral arteries in pulmonary atresia with ventricular septal defect is essential to achieve excellent outcomes irrespective of native pulmonary artery morphology.J Thorac Cardiovasc Surg.2009; 138(6):1269-75.
[85]Marasini M, Gorrieri PF, Tuo G,et al.Long-term results of catheter-based treatment of pulmonary atresia and intact ventricular septum.Heart.2009;95(18): 1520-4.
[86]Li S, Chen W, Zhang Y,et al. Hybrid therapy for pulmonary atresia with intact ventricular septum. Ann Thorac Surg.2011;91(5):1467-71.
[87]Fenton KN, Pigula FA, Gandhi SK,et al.Interim mortality in pulmonary atresia with intact ventricular septum.Ann Thorac Surg.2004;78(6):1994-8.
[88]John AS, Warnes CA. Clinical outcomes of adult survivors of pulmonary atresia with intact ventricular septum.Int J Cardiol.2011.Epub ahead of print
[89]Rychik J, Levy H, Gaynor JW,et al. Outcome after operations for pulmonary atresia with intact ventricular septum J Thorac Cardiovasc Surg.1998; 116(6): 924-31.
[90]Ashburn DA, Blackstone EH, Wells WJ, et al. Determinants of mortality and type of repair in neonates with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg.2004; 127:1000-1007.
[91]Dyamenahalli U, McCrindle BW, McDonald C,et al. Pulmonary atresia with intact ventricular septum:management of,and outcomes for,a cohort of 210 consecutive patients. Cardiol Young.2004;14:299-308.
[92]Ekman Joelsson BM, Sunnegardh J, Hanseus K,et al.The outcome of children born with pulmonary atresia and intact ventricular septum in Sweden from 1980 to 1999. Scand Cardiovasc J.2001;35:192-198.
[93]Odim J, Laks H, Plunkett MD,et al.Successful management of patients with pulmonary atresia with intact ventricular septum using a three tier grading system for right ventricular hypoplasia.Ann Thorac Surg.2006; 81:678-684.
[94]Mair DD, Julsrud PR, Puga FJ,et al. The Fontan procedure for pulmonary atresia with intact ventricular septum:operative and late results. J Am Coll Cardiol.1997; 29:1359-64.
[95]Najm HK, Williams GW, Coles JG,et al.Pulmonary atresia with intact ventricular septum:results of the Fontan procedure.Ann Thorac Surg.1997;63:669-75.
[96]Hannan RL, Zabinsky JA, Stanfill RM,et al.Midterm results for collaborative treatment of pulmonary atresia with intact ventricular septum.Ann Thorac Surg.2009;87(4):1227-33.
[97]Daubeney PE, Wang D, Delany DJ,et al.Pulmonary atresia with intact ventricular septum:predictors of early and medium-term outcome in a population-based study J Thorac Cardiovasc Surg.2005;130:1071.
[98]Mishima A, Asano M, Sasaki S,et al. Long-term outcome for right heart function after biventricular repair of pulmonary atresia and intact ventricular septum.Jpn J Thorac Cardiovasc Surg.2000;48:145-152.
[99]Sanghavi DM, Flanagan M, Powell AJ,et al.Determinants of exercise function following univentricular versus biventricular repair for pulmonary atresia/intact ventricular septum. Am J Cardiol.2006;97:1638-1643.
[100]Ekman-Joelsson BM, Gustafsson PM, Sunnegardh J.Exercise performance after surgery for pulmonary atresia and intact ventricular septum.Pediatr Cardiol.2009; 30:752-762.
[101]Mi YP, Cheung YF.Assessment of right and left ventricular function by tissue Doppler echocardiography in patients after biventricular repair of pulmonary atresia with intact ventricular septum. Int J Cardiol.2006; 109:329-334.
[102]Numata S, Uemura H, Yagihara T,et al. Long-term functional results of the one and one half ventricular repair for the spectrum of patients with pulmonary atresia/stenosis with intact ventricular septum.Eur J Cardiothorac Surg.2003;24: 516-520.
[103]Pantely GA. Pulmonary atresia with ventricular septal defect.In:Gatzoulis MA, Swan L, Therrien J, et al. editor.Adult Congenital Heart Disease.Malden, MA: Blackwell;2005.p136.
[104]Cho JM, Puga FJ, Danielson GK,et al.Early and long-term results of the surgical treatment of tetralogy of Fallot with pulmonary atresia, with or without major aortopulmonary collateral arteries.J Thorac Cardiovasc Surg.2002; 124(1): 70-81.
[2]Leonard H, Derrick G, O'Sullivan J,et al.Natural and unnatural history of pulmonary atresia.Heart.2000,84(5):499-503.
[3]Tchervenkov CI, Roy N. Congenital Heart Surgery Nomenclature and Database Project:pulmonary atresia--ventricular septal defect.Ann Thorac Surg.2000;69(4 Suppl):S97-105.
[4]Agnoletti G, Piechaud JF, Bonhoeffer P,et al. Perforation of the atretic pulmonary valve:Long-term follow-up. J Am Coll Cardiol.2003;41(8):1399-403.
[5]Alwi M, Geetha K, Bilkis AA, et al. Pulmonary atresia with intact ventricular septum:percutaneous radiofrequency-assisted valvotomy and balloon dilation versus surgical valvotomy and Blalock-Taussig shunt.J Am Coll Cardiol. 2000;35:468-76.
[6]陈纲,刘芳,吴琳,等.经右室穿刺肺动脉瓣球囊扩张治疗室间隔完整型肺动脉闭锁.中华小儿外科杂志,2011,32(4)：262-4.
[7]董卫,张海波.室间隔完整型肺动脉闭锁的镶嵌治疗.上海交通大学学报(医学版),2011,31(9)：1291-4.
[8]胡盛寿,李守军,张浩,等.“杂交”技术治疗新生儿期室间隔完整的肺动脉闭锁.中华胸心血管外科杂志,2006,22(6)：376-7.
[9]Marasini M, Gorrieri PF, Tuo G,et al.Long-term results of catheter-based treatment of pulmonary atresia and intact ventricular septum. Heart.2009;95(18):1520-4.
[10]Azakie A, McCrindle BW, Van Arsdell G,et al. Extracardiac conduit versus lateral tunnel cavopulmonary connections at a single institution:impact on outcomes. J Thorac Cardiovasc Surg.2001; 122(6):1219-28.
[11]梅举,张宝仁,杨小龙,等.非体外循环下改良全腔静脉-肺动脉连接术.中华胸心血管外科杂志,2002,18(6)：325-7.
[12]许建屏,罗新锦,吴清玉,等.非体外循环下全腔静脉肺动脉连接术的临床 应用.中华胸心血管外科杂志,2004,20(2)：84-6.
[13]Dyamenahalli U, McCrindle BW, McDonald C,et al. Pulmonary atresia with intact ventricular septum:management of, and outcomes for, a cohort of 210 consecutive patients. Cardiol Young 2004;14:299-308.\
[14]Bautista-Hernandez V, Hasan BS, Harrild DM,et al. Late pulmonary valve replacement in patients with pulmonary atresia and intact ventricular septum:a case-matched study. Ann Thorac Surg.2011;91(2):555-60.
[15]Shinkawa T, Yamagishi M, Shuntoh K,et al. One-stage definitive repair of pulmonary atresia with intact ventricular septum and hypoplastic right ventricle.J Thorac Cardiovasc Surg.2005;130(4):1207-8.
[16]J Stark,M de Leval,VT Tsang.Surgery for Congenital Heart Defects. Wiley-Blackwell.2006,pp411-22.
[17]Jonas RA,Tetralogy of Fallot with pulmonary atresia,in Comprehensive surgical management of congenital heart disease.R.A. Jonas,Edition.2004.p440-56.
[18]Reddy VM, Liddicoat JR, Hanley FL. Midline one-stage complete unifocalization and repair of pulmonary atresia with ventricular septal defect and major aortapulmonary collaterals. J Thorac Cardiovasc Surg.1995; 109:832-845.
[19]d'Udekem Y, Alphonso N, N(?)rgaard MA,et al. Pulmonary atresia with ventricular septal defects and major aortopulmonary collateral arteries:unifocalization brings no long-term benefits. J Thorac Cardiovasc Surg.2005; 130(6):1496-502.
[20]Brizard CP, Liava'a M, d'Udekem Y. Pulmonary atresia, VSD and Mapcas:repair without unifocalization. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009:139-44.
[21]Duncan BW, Mee RB, Prieto LR,et al. Staged repair of tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg.2003;126(3):694-702.
[22]Mumtaz MA, Rosenthal G, Qureshi A,et al. Melbourne shunt promotes growth of diminutive central pulmonary arteries in patients with pulmonary atresia, ventricular septal defect, and systemic-to-pulmonary collateral arteries.Ann Thorac Surg.2008; 85(6):2079-83.
[23]Bradley SM, Erdem CC, Hsia TY,et al. Right ventricle-to-pulmonary artery shunt: alternative palliation in infants with inadequate pulmonary blood flow prior to two-ventricle repair. Ann Thorac Surg.2008;86(1):183-8.
[24]邓喜成.先天性肺动脉闭锁合并室间隔缺损的回顾性临床研究与全基因组拷贝数变异分析.长沙：中南大学,2010.
[25]郑景浩,徐志伟,苏肇伉,等.小儿肺动脉闭锁伴室间隔缺损右室流出道重建方法.中华胸心血管外科杂志,2005,21(5)：257-9.
[26]Reddy VM, McElhinney DB, Amin Z,et al. Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries:experience with 85 patients. Circulation.2000; 101:1826-1832.
[27]Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart disease.The genetic-environmental interaction.Circulation.1968,38:604-617.
[28]Sebat J, Lakshmi B, Troge J,et al. Large-scale copy number polymorphism in the human genome.Science.2004;305(5683):525-8.
[29]Redon R, Ishikawa S, Fitch KR,et al. Global variation in copy number in the human genome. Nature.2006;444(7118):444-54.
[30]杜仁骞,金力,张锋.基因组拷贝数变异及其突变机理与人类疾病.遗传.2011,33(8)：857-869.
[31]Drake JA, et al. Conserved noncoding sequences are selectively constrained and not mutation cold spots. Nat Genet.2006;38:223-7.
[32]Freeman JL, Perry GH, Feuk L,et al. Copy number variation:new insights in genome diversity.Genome Res.2006;16(8):949-61. Epub 2006 Jun 29.
[33]Singleton AB, Farrer M, Johnson J,et al.alpha-Synuclein locus triplication causes Parkinson's disease.Science.2003;302(5646):841.
[34]Cooper GM, Coe BP, Girirajan S,et al. A copy number variation morbidity map of developmental delay. Nat Genet.2011;43(9):838-46.
[35]Sebat, J., Lakshmi, B., et al. Strong association of de novo copy number mutations with autism. Science.2007; 316:445-449.
[36]Cook EH, et al. Copy-number variations associated with neuropsychiatric conditions.Nature,2008; 455(7215):919-923.
[37]Carter NP. Methods and strategies for analyzing copy number variation using DNA microarrays.Nat Genet.2007;39(7 Suppl):S16-21.
[38]Pierpont ME, Basson CT, Benson DW, et al.Genetic basis for congenital heart defects:current knowledge:a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on cardiovascular disease in the young. Circulation.2007; 115:3015-3038.
[39]Garg V.Insights into the genetic basis of congenital heart disease. Cell Mol Life Sci.2006; 63:1141-1148.
[40]Lammer E, Chak J, Iovannisci D, et al. Chromosomal abnormalities among children born with conotruncal cardiac defects. Birth Defects Res.2009;85:30-35.
[41]Goldmuntz E, Clark BJ, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol.1998; 32:492-498.
[42]Ensenauer RE,Adeyinka A,Flynn HC,et al.Microduplication 22q11.2,an emerging syndrome:clinical, cytogenic, and molecular analysis of thirteen patients. Hum Genet.2003;73:1027-1040.
[43]Vissers LE, van Ravenswaaij CM, Admiraal R,et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.Nat Genet.2004;36(9):955-7.
[44]Janssen N, Bergman JE, Swertz MA,et al. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat.2012 Mar 27. [Epub ahead of print]
[45]Greenway SC, Pereira AC, Lin JC, et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot.Nat Genet.2009;41: 931-935.
[46]Database of Genomic Variants, http://proiects.tcag.ca/variation/
[47]Pinto D, Darvishi K, Shi X,et al. Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechnol.2011;29(6):512-20.
[48]Brunet A,Armengol L,Heine D,et al.BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1. BMC Med Genet.2009;10:144.
[49]Nakamura E,Makita Y,Okamoto T,et al.5.78 Mb terminal deletion of chromosome 15q in a girl, evaluation of NR2F2 as candidate gene for congenital heart defects. Eur J Med Genet.2011;54(3):354-6.
[50]Burn J and Goodship J (1996) Congenital heart disease. In Rimoin DL, Conner JM, Pyeritz RE and Emery AEH(eds),Emery and Rimoin's Principles and Practice of Medical Genetics.Churchill Livingstone, New York, Vol.1, pp.767-803.
[51]Jerome LA, Papaioannou VE. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbxl. Nat Genet.2001;27:286-91.
[52]Lindsay EA, Vitelli F, Su H,et al. Tbxl haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature.2001;410:97-101.
[53]Merscher S, Funke B, Epstein JA,et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell.2001;104:619-29.
[54]Momma K. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome.Am J Cardiol.2010;105(11):1617-24.
[55]van Engelen K, Topf A, Keavney BD,et al.22q11.2 Deletion Syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia.Heart.2010;96(8):621-4.
[56]Lee Y, Song A, Baker R, et al. Jumonji, a nuclear protein that is necessary for normal heart development. Circ Res.2000;86:932-938.
[57]Ou Z, Berg H, Yonath VB, et al.Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes.Genet Med.2008;4:267-77.
[58]Ensenauer RE,Adeyinka A,Flynn HC.et al.Microduplication 22q11.2,an emerging syndrome:clinical,cytogenic, and molecular analysis of thirteen patients.Hum Genet.2003;73:1027-1040.
[591 Zweier C, Sticht H, Aydin-Yaylagul I, et al. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.Am J Hum Genet.2007; 80:510-517.
[60]Fernandez TV, Garcia-Gonzalez IJ, Mason CE,et al. Molecular characterization of a patient with 3p deletion syndrome and a review of the literature. Am J Med Genet A,2008 Nov 1;146A(21):2746-52.
[61]Guilherme RS, Bragagnolo S, Pellegrino R,et al. Clinical, cytogenetic and molecular study in a case of r(3) with 3p deletion and review of the literature. Cytogenet Genome Res.2011;134(4):325-30.
[62]Fernandez T, Morgan T, Davis N,et al. Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am J Hum Genet.2004;74(6):1286-93.
[63]Saunders IW,Ross J,Macrae F,et al.Evidence of linkage to chromosomes 10p15.3-p15.1,14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families.Eur J Hum Genet.2012;20(1):91-6.
[64]Leuraud P,Aguirre-Cruz L,Hoang-Xuan K,et al.Telomerase reactivation in malignant gliomas and loss of heterozygosity on 10p15.1.Neurology.2003;60 (11):1820-2.
[65]Firth HV,Richards SM,Bevan AP,Clayton S, Corpas M, Rajan D, Van VS,Moreau Y, Pettett RM, Carter NP. DECIPHER:Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources.Am J Hum Genet.2009;84:524-533.
[66]Tremblay N, Yang SW, Hitz MP,et al.Familial ventricular aneurysms and septal defects map to chromosome 10p15. Eur Heart J.2011;32(5):568-73.
[67]DiFeo A,Martignetti JA,Narla GThe role of KLF6 and its splice variants in cancer therapy. Drug Resist Updat.2009;12(1-2):1-7.
[68]Spinola M, Leoni VP, Galvan A, et al. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene.Cancer Lett. 2007;251(2):311-6.
[69]Gehrau RC, D'Astolfo DS, Dumur CI,et al. Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.PLoS One.2010;28;5(1):e8929.
[70]Zhang Q. Tan XP, Yuan YS,et al. Decreased expression of KLF6 and its significance in gastric carcinoma.Med Oncol.2010;27(4):1295-302.
[71]De Stefano D, Li P, Xiang B,et al.Pulmonary atresia with intact ventricular septum (PA-IVS) in monozygotic twins.Am J Med Genet A.2008;15;146A(4): 525-8.
[72]Pinson L, Perrin A, Plouzennec C,et al. Detection of an unexpected subtelomeric 15q26.2-> qter deletion in a little girl:clinical and cytogenetic studies.Am J Med Genet A.2005;138A(2):160-5.
[73]Russo VC,Gluckman PD,Feldman EL,et al.The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev.2005;26(7):916-43.
[74]Inagaki K,Tiulpakov A,Rubtsov P,et al.A familial insulin-like growth factor-I receptor mutant leads to short stature:clinical and biochemical characterization.J Clin Endocrinol Metab.2007;92(4):1542-8.
[75]Abuzzahab MJ, Schneider A, Goddard A,et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation.N Engl J Med.2003;349(23):2211-22.
[76]Liu JP, Baker J, Perkins AS, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr).Cell. 1993;75(1):59-72.
[77]Davidsson J, Collin A, Bjorkhem G,et al. Array based characterization of a terminal deletion involving chromosome subband 15q26.2:an emerging syndrome associated with growth retardation, cardiac defects and developmental delay. BMC Med Genet.2008;14;9:2.
[78]Ester WA, van Duyvenvoorde HA, de Wit CC,et al. Two short children born small for gestational age with insulin-like growth factor 1 receptor haploinsufficiency illustrate the heterogeneity of its phenotype.J Clin Endocrinol Metab.2009;94(12):4717-27.
[79]Poot M, Eleveld MJ, van't Slot R,et al. Proportional growth failure and oculocutaneous albinism in a girl with a 6.87 Mb deletion of region 15q26.2--> qter.Eur J Med Genet.2007;50(6):432-40.
[80]Rujirabanjerd S, Suwannarat W, Sripo T,et al. De novo subtelomeric deletion of 15q associated with satellite translocation in a child with developmental delay and severe growth retardation.Am J Med Genet A.2007;143(3):271-6.
[81]Rump P, Dijkhuizen T, Sikkema-Raddatz B,et al.Drayer's syndrome of mental retardation, microcephaly, short stature and absent phalanges is caused by a recurrent deletion of chromosome 15(q26.2-->qter).Clin Genet.2008;74(5):455-62.
[82]Pereira FA, Qiu Y,Zhou G, et al. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development.Genes Dev.1999;13(8):1037-49.
[83]Gruber PJ, Epstein JA. Development gone awry:congenital heart disease.Circ Res.2004;94(3):273-83.
[84]Schlueter PJ,Royer T Farah MH,et al.Gene duplication and functional divergence of the zebrafish insulin-like growth factor 1 receptors.FASEB J.2006;20(8):1230-2.
[85]Schlueter PJ, Peng G, Westerfield M,et al. Insulin-like growth factor signaling regulates zebrafish embryonic growth and development by promoting cell survival and cell cycle progression.Cell Death Differ.2007;14(6):1095-105.
[86]Hennekam RC.Rubinstein-Taybi syndrome.Eur J Hum Genet.2006;14(9):981-5.
[87]Rubinstein JH, Taybi H.1963. Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child.105:588-608.
[88]Yamano G, Funahashi H, Kawanami O,et al. ABCA3 is a lamellar body membrane protein in human lung alveolar type Ⅱ cells.FEBS Lett.2001;508(2): 221-5.
[89]Hallman M. Lung surfactant, respiratory failure, and genes.N Engl J Med.2004; 350:1278-80.
[90]Nagata K, Yamamoto A, Ban N,et al. Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles.Biochem Biophys Res Commun.2004;324(l):262-8.
[91]Shulenin S, Nogee LM, Annilo T, et al. ABC A3 genemutations in newborns with fatal surfactant deficiency. N Engl J Med.2004;350:1296-303.
[92]Garmany TH, Wambach JA, Heins HB,et al. Population and disease-based prevalence of the common mutations associated with surfactant deficiency.Pediatr Res.2008;63(6):645-9.
[93]Matsumura Y, Ban N. Ueda K,et al. Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fata1 surfactant deficiency.J Biol Chem.2006;281(45):34503-14.
[94]江林,杜立中ABCA3基因突变在新生儿呼吸窘迫综合征的研究进展.国际儿科学杂志.2009；36(5)：474-6.
[95]Cuello F, Bardswell SC, Haworth RS,et al. Protein kinase D selectively targets cardiac troponin I and regulates myofilament Ca2+ sensitivity in ventricular myocytes. Circ Res.2007;100(6):864-73.
[96]Fielitz J, Kim MS, Shelton JM,et al. Requirement of protein kinase Dl for pathological cardiac remodeling.Proc Natl Acad Sci U S A .2008;105(8):3059-63.
[97]Li C, Li J, Cai X,et al. Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors.J Biol Chem.2011;286(47):40782-91.
[98]Benson DW, Silberback GM, Kavanaugh-McHugh A, et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest.1999;104:1567-1573.
[99]Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation.2001;104:2565-2568.
[100]Garg V, Kathiriya IS, Barnes R, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature.2003; 424:443-447.
[101]Lorson CL, Hahnen E, Androphy EJ,et al. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A.1999;96(11):6307-11.
[102]Cartegni L, Krainer AR. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet.2002;30(4):377-84.
[103]Heier CR, DiDonato CJ.Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo. Hum Mol Genet.2009; 18(7):1310-22.
[104]Shababi M, Habibi J, Yang HT, et al. Cardiac defects contribute to the pathology of spinal muscular atrophy models.Hum Mol Genet.2010;19(20):4059-71.
[105]Lefebvre S, Burglen L, Reboullet S,et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell.1995;80:155-65.
[106]Jedrzejowska M, Milewski M, Zimowski J,et al. Phenotype modifiers of spinal muscular atrophy:the number of SMN2 gene copies, deletion in the NAEP gene and probably gender influence the course of the disease. Acta Biochim. 2009;56:103-8.
[107]Mulleners WM, van Ravenswaay CM, Gabreels FJ,et al. Spinal muscular atrophy combined with congenital heart disease:a report of two cases. Neuropediatrics.1996;27:333-4.
[108]Rudnik-Schoneborn S, Heller R, Berg C, et al.Congenital heart disease is a feature of severe infantile spinal muscular atrophy. Med Genet.2008;45:635-8.
[109]Moller P, Moe N, Saugstad OD, et al. Spinal muscular atrophy type i combined with atrial septal defect in three sibs. Clin Genet.1990;38:81-3.
[110]Bevan AK,Hutchinson KR,Foust KD, et al.Early heart failure in the SMN{delta} 7 model of spinalmuscular atrophy and correction by postnatal scAAV9-smn delivery. Hum Mol Genet.2010;19(20):3895-905.
[111]Heier CR, Satta R, Lutz C,et al. Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice.Hum Mol Genet.2010;19(20):3906-18.
[112]Shababi M, Habibi J, Ma L,et al. Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy. J Mol Cell Cardiol.2012. Epub ahead of print.
[113]Giugliani R, Harmatz P, Wraith JE. Management guidelines for mucopoly-saccharidosis VI. Pediatrics.2007;120(2):405-18. Review.
[114]Gottwald I, Hughes J, Stewart F,et al. Attenuated mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) due to homozygosity for the p.Y210C mutation in the ARSB gene.Mol Genet Metab.2011;103(3):300-2.
[115]Marwick TH,Bastian B,Hughes CF,et al. Mitral stenosis in the Maroteaux-Lamy syndrome:a treatable cause of dyspnoea.Postgrad Med J.1992;68(798):287-8.
[116]Tan CT, Schaff HV, Miller FA Jr,et al. Valvular heart disease in four patients with Maroteaux-Lamy syndrome.Circulation.1992;85(1):188-95.
[117]Wilson CS, Mankin HT, Pluth JR. Aortic stenosis and mucopolysaccharidosis. Ann Intern Med.1980;92(4):496-8.
[118]Swiedler SJ,Beck MJBajbouj M,et al.Threshold effect of urinary glycosamino-glycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).Am J Med Genet A.2005;134A(2):144-50.
[119]Azevedo AC, Schwartz IV, Kalakun L,et al.Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI. Clin Genet.2004;66(3):208-13.
[120]Jurecka A, Golda A, Opoka-Winiarska V,et al. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype.Mol Genet Metab.2011;104(4):695-9.
[1]Leonard H, Derrick G, O'Sullivan J,et al. Natural and unnatural history of pulmonary atresia.Heart.2000,84(5):499-503.
[2]Mavroudis C,Backer CL.Pediatric cardiac surgery,ed 3, Singapore,2004, Elsevier.
[3]Kutsche LM, Van Mierop LHS. Pulmonary atresia with and without ventricular septal defect:a different etiology and pathogenesis for the atresia in the 2 types? Am J Cardiol.1983;51:932-5.
[4]Stuckey D,Bowdler JD,Reye RD.Absent sixth aortic arch:a form of pulmonary atresia.Br Heart J.1968,30(2):258-64.
[5]汪曾炜,刘维永,张宝仁。心脏外科学,第一版,2003年,人民军医出版社。
[6]Marino B, Calabro R, Gagliardi MG, et al. Patterns of pulmonary arterial anatomy and blood supply in complex congenital heart disease with pulmonary atresia. J Thorac Cardiovasc Surg.1987,94(4):518-20.
[7]Boshoff D, Gewillig M.A review of the options for treatment of major aortopulmonary collateral arteries in the setting of tetralogy of Fallot with pulmonary atresia. Cardiol Young.2006,16(3):212-20.
[8]Reddy VM, Liddicoat JR, Hanley FL. Midline one-stage complete unifocalization and repair of pulmonary atresia with ventricular septal defect and major aortapulmonary collaterals. J Thorac Cardiovasc Surg.1995; 109:832-845.
[9]Liao P,Edwards WD, Julsrud PR,et al. Pulmonary blood supply in patients with pulmonary atresia and ventricular septal defect.J Am Coll Cardiol.1985;6:1343-1350.
[10]Amin Z, McElhinney DB, Reddy M,et al. Coronary to pulmonary artery collaterals in patients with pulmonary atresia and ventricular septal defect. Ann Thorac Surg.2000;70:119-123.
[11]Thiene G, Frescura C, Bini RM. et al. Histology of pulmonary arterial supply in pulmonary atresia with ventricular septal defect. Circulation.1979;60:1066-1074.
[12]McElhinney DB, Reddy VM, Hanley FL. Tetralogy of Fallot with major aortopulmonary collaterals:early total repair. Pediatr Cardiol.1998;19:289-296.
[13]Permut LC, Laks H, Aharon A. Surgical management of pulmonary atresia with ventricular septal defect and multiple aortopulmonary collaterals.Isr J Med Sci. 1994; 30:215-224.
[14]Freedom RM, Rabinovitch M. Pulmonary atresia and ventricular septal defect. In: Freedom RM, Benson LN, Smallhorn JF (eds).Neonatal Heart Disease. Springer-Verlag, London,1992,pp229-256.
[15]Edwards JE, McGoon DC. Absence of anatomic origin from heart of pulmonary arterial supply. Circulation.1973;47:393-8.
[16]McGoon DC, Baird DK, Davis GD. Surgical management of large bronchial collateral arteries with pulmonary stenosis or atresia. Circulation.1975;52:109-18.
[17]Rabinovitch M, Herrera-deLeon V, Castaneda AR,et al. Growth and development of the pulmonary vascular bed in patients with tetralogy of Fallot with or without pulmonary atresia. Circulation.1981;64:1234-49.
[18]Bull C, de Leval MR, Mercanti C,et al. Pulmonary atresia and intact ventricular septum:a revised classification. Circulation.1982;66:266-72.
[19]Mavroudis C,Backer CL.Pediatric Cardiac Surgery.Elsevier, Singapore,2004, pp324-339.
[20]Gittenberger-de Groot AC, Sauer U, Bindl L,et al. Competition of coronary arteries and ventriculo-coronary arterial communications in pulmonary atresia with intact ventricular septum. Int J Cardiol.1988;18(2):243-58.
[21]Barbero-Marcial M, Jatene AD. Surgical management of the anomalies of the pulmonary arteries in the tetralogy of Fallot with pulmonary atresia. Semin Thorac Cardiovasc Surg.1990; 2:93-107.
[22]Tchervenkov CI, Roy N. Congenital Heart Surgery Nomenclature and Database Project:pulmonary atresia--ventricular septal defect.Ann Thorac Surg.2000;69(4 Suppl):S97-105.
[23]J Stark,M de Leval,VT Tsang. Surgery for Congenital Heart Defects. Wiley-Blackwell.2006,pp411-22.
[24]Lofland GK.Progress in Pediatric Cardiology.Elsevier.2009, pp55-59.
[25]Van Arsdell G, Yun TJ. An apology for primary repair of tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu.2005;128-31.
[26]Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot in the neonate:results in the modern era.Ann Surg.2000;232:508-14.
[27]Hennein HA, Mosca RS, Urcelay G.et al.Intermediate results after complete repair of tetralogy of Fallot in neonates. J Thorac Cardiovasc Surg.1995;109:332-44.
[28]Kwak JG, Lee CH, Lee C,et al. Surgical management of pulmonary atresia with ventricular septal defect:early total correction versus shunt. Ann Thorac Surg. 2011;91(6):1928-34.
[29]Lillehei CW,Cohen M,Warden HE,et al.Direct vision intracardiac surgical correction of the tetralogy of Fallot, pentalogy of Fallot, and pulmonary atresia defects; report of first ten cases. Ann Surg.l955;142(3):418-42.
[30]Bowman FO Jr, Malm JR, Hayes CJ,et al.Pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg.1971;61:85-95.
[31]Haworth SG,Rees PG, Taylor JF,et al. Pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. Effect of systemic pulmonary anastomosis. Br Heart J.1981;45:133-41.
[32]Nakanishi T. Balloon dilation and stent implantation for vascular stenosis. Pediatr Int.2001;43:548-52.
[33]Holzer R, Chrisolm J, Hill S, et al. "Hybrid" stent delivery in the pulmonary circulation. J Invasive Cardiol.2008;20:592-8.
[34]Brown SC, Eyskens B, Mertens L,et al. Percutaneous treatment of stenosed major aortopulmonary collaterals with balloon dilatation and stenting:what can be achieved? Heart.1998;79:24-8.
[35]Cleuziou J, Schreiber C, Eicken A,et al. Predictors for biventricular repair in pulmonary atresia with intact ventricular septum.Thorac Cardiovasc Surg.2010; 58:339-44.
[36]Foker JE, Setty SP, Berry J,et al. Treatment of right ventricle to coronary artery connections in infants with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg.2008; 136:749-56.
[37]Akagi T, Benson LN, Williams WG,et al. Ventriculocoronary arterial connections in pulmonary atresia with intact ventricular septum, and their influences on ventricular performance and clinical course. Am J Cardiol.1993;72: 586-90.
[38]Yoshimura N, Yamaguchi M. Surgical strategy for pulmonary atresia with intact ventricular septum:initial management and definitive surgery. Gen Thorac Cardiovasc Surg.2009;57(7):338-46.
[39]Giglia TM, Jenkins KJ, Matitiau A,et al. Influence of right heart size on outcome in pulmonary atresia with intact ventricular septum.Circulation.1993;88:2248-56.
[40]Shaddy RE, Sturtevant JE, Judd VE, et al. Right ventricular growth after transventricular pulmonary valvotomy and central aortopulmonary shunt for pulmonary atresia and intact ventricular septum.Circulation.1990;82(5 Suppl): Ⅳ157-63.
[41]Lewis AB, Wells W, Lindesmith GG. Right ventricular growth potential in neonates with pulmonary atresia and intact ventricular septum.J Thorac Cardiovasc Surg.1986;91 (6):835-40.
[42]Shinkawa T, Yamagishi M, Shuntoh K,et al. One-stage definitive repair of pulmonary atresia with intact ventricular septum and hypoplastic right ventricle. J Thorac Cardiovasc Surg.2005;130(4):1207-8.
[43]McCaffrey FM, Leatherbury L, Moore HV. Pulmonary atresia and intact ventricular septum:defi nitive repair in the neonatal period. J Thorac Cardiovasc Surg.1991;102:617-23.
[44]Rychik J, Levy H, Gaynor JW,et al.Outcome after operations for pulmonary atresia with intact ventricular septum.J Thorac Cardiovasc Surg.1998;116:924-31.
[45]Yoshimura N, Yamaguchi M, Ohashi H,et al. Pulmonary atresia with intact ventricular septum:strategy based on right ventricular morphology. J Thorac Cardiovasc Surg.2003;126(5):1417-26.
[46]Bull C, Kostelka M, Sorensen K,et al. Outcome measures for the neonatal management of pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg.1994; 107:359-66.
[47]Hanley FL, Sade RM, Blackstone EH,et al.Outcomes in neonatal pulmonary atresia with intact ventricular septum. A multiinstitutional study. J Thorac Cardiovasc Surg.1993; 105:406-27.
[48]Gentles TL, Colan SD, Giglia TM,et al. Right ventricular decompression and left ventricular function in pulmonary atresia with intact ventricular septum:the influence of less extensive coronary anomalies. Circulation.1993;88:183-8.
[49]Jahangiri M, Zurakowski D, Bichell D,et al. Improved results with selective management in pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg.1999; 118:1046-55.
[50]Sano S, Ishino K, Kawada M,et al. Staged biventricular repair of pulmonary atresia or stenosis with intact ventricular septum. Ann Thorac Surg.2000;70:1501-6.
[51]Hawkins JA, Thorne JK, Boucek MM, et al. Early and late results in pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg.1990:100:492-7.
[52]Shaddy RE, Sturtevant JE, Judd VE,et al. Right ventricular growth after transventricular pulmonary valvotomy and central aortopulmonary shunt for pulmonary atresia and intact ventricular septum.Circulation.1990;82(IV):157-63.
[53]Joshi SV,Brawn WJ,Mee RBB.Pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg.1986;91:192-9.
[54]Hirata Y, Chen JM, Quaegebeur JM,et al. Pulmonary atresia with intact ventricular septum:limitations of catheter-based intervention. Ann Thorac Surg. 2007;84:574-80.
[55]Ovaert C, Qureshi SA, Rosenthal E,et al.Growth of the right ventricle after transcatheter pulmonary valvotomy in neonates and infants with pulmonary atresia and intact ventricular septum.J Thorac Cardiovasc Surg.1998; 115:1055-62.
[56]McLean KM, Pearl JM. Pulmonary atresia with intact ventricular septum:initial management. Ann Thorac Surg.2006;82:2214-20.
[57]Alwi M, Geetha K, Bilkis AA, et al. Pulmonary atresia with intact ventricular septum:percutaneous radiofrequency-assisted valvotomy and balloon dilation versus surgical valvotomy and Blalock-Taussig shunt..J Am Coll Cardiol.2000;35: 468-76.
[58]Zhang H, Li SJ, Li YQ,et al. Hybrid procedure for the neonatal management of pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg.2007; 133(6):1654-6.
[59]Coles JG, Freedom RM, Lightfoot NE,et al. Long-term results in neonates with pulmonary atresia and intact ventricular septum.Ann Thorac Surg.1989;47:213-7.
[60]Reddy VM,Ungerleider RM,Hanley FL:Pulmonary valve atrsia with intact ventricular septum.In Garson AG Jr,Brickner JT,Fischer DJ,et al,eds:The science and practice of pediatric cardiology,ed 2,Baltimore,1998,Williams& Wilkins.
[61]Yamaguchi M, Ohashi H, Oshima Y,et al. Transpulmonary open-valvotorny and later defi nitive repair for pulmonary atresia with intact ventricular septum. In: Proceedings of the 2nd World Congress of Pediatric Cardiology and Cardiac Surgery,1998,pp798-800.
[62]McGoon DC, Baird DK, Davis GD. Surgical management of large bronchial collateral arteries with pulmonary stenosis or atresia.Circulation.1975;52:109-118.
[63]Nakata S, Imai Y, Takanashi Y,et al.A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. J Thorac Cardiovasc Surg. 1984;88:610-619.
[64]Pigula FA, Khalil PN, Mayer JE,et al. Repair of tetralogy of Fallot in neonates and young infants. Circulation.1999;100:Ⅱ157-61.
[65]Kwak JG, Lee CH, Lee C,et al. Surgical management of pulmonary atresia with ventricular septal defect:early total correction versus shunt. Ann Thorac Surg. 2011;91(6):1928-34.
[66]Watterson KG, Wilkinson JL, Karl TR,et al. Very small pulmonary arteries: central end-to-side shunt.Ann Thorac Surg.1991;52:1132-7,
[67]Duncan BW, Mee RB, Prieto LR,et al. Staged repair of tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg.2003; 126:694-702.
[68]Puga FJ, Leoni FE, Julsrud PR,et al. Complete repair of pulmonary atresia, ventricular septal defect and severe peripheral arborization abnormalities of central pulmonary arteries. J Thorac Cardiovasc Surg.l989;98:1018-1029.
[69]Iyer KS, Mee RB.Staged repair of pulmonary atresia with ventricular septal defect and major systemic to pulmonary artery collaterals.Ann Thorac Surg.1991; 51:65-72.
[70]Marelli JA, Perloff KJ, Child SJ,et al. Pulmonary atresia with ventricular septal defect in adults.Circulation.1994;89:243-251.
[71]Reddy VM, McElhinney DB, Amin Z,et al. Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries:experience with 85 patients.Circulation.2000; 101:1826-1832.
[72]Lofland GK. The management of pulmonary atresia, ventricular septal defect, and multiple aorto-pulmonary collateral arteries by definitive single stage repair in early infancy. Eur J Cardiothorac Surg.2000;18:480-486.
[73]Abella RF, De La Torre T, Mastropietro G,et al. Primary repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals:a useful approach. J Thorac Cardiovasc Surg.2004; 127:193-202.
[74]Puga FJ, Leoni FE, Julsrud PR,et al. Complete repair of pulmonary atresia, ventricular septal defect, and severe peripheral arborization abnormalities of the central pulmonary arteries.Experience with preliminary unifocalization procedures in 38 patients. J Thorac Cardiovasc Surg.l989;98(6):1018-28.
[75]Reddy VM, Petrossian E, McElhinney DB et al. One-stage complete unifocalization in infants:when should the ventricular septal defect be closed? J Thorac Cardiovasc Surg.1997;113:858-68.
[76]Carotti A, Di Donato RM, Squitieri C,et al. Total repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals:an integrated approach. J Thorac Cardiovasc Surg.1998;116:914-923.
[77]Mei J, Ding FB, Zhu JQ,et al.A novel two-stage complete repair method for pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. Chin Med J (Engl).2010;123(3):259-64.
[78]Murthy KS, Krishnanaik S, Coelho R,et al. Median sternotomy single stage complete unifocalization for pulmonary atresia, major aorto-pulmonary collateral arteries and VSD-early experience.Eur J Cardiothorac Surg.l999;16(1):21-5.
[79]Murthy KS, Rao SG, Naik SK,et al. Evolving surgical management for ventricular septal defect, pulmonary atresia, and major aortopulmonary collateral arteries. Ann Thorac Surg.l 999;67(3):760-4.
[80]Griselli M, McGuirk SP, Winlaw DS,et al.The influence of pulmonary artery morphology on the results of operations for major aortopulmonary collateral arteries and complex congenital heart defects.J Thorac Cardiovasc Surg.2004;127: 251-258.
[81]d'Udekem Y, Alphonso N, N(?)rgaard MA,et al.Pulmonary atresia with ventricular septal defects and major aortopulmonary collateral arteries:unifocalization brings no long-term benefits.J Thorac Cardiovasc Surg.2005;130(6):1496-502.
[82]Brizard CP, Liava'a M, d'Udekem Y.Pulmonary atresia,VSD and Mapcas:repair without unifocalization.Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009; 139-44.
[83]Liava'a M, Brizard CP, Konstantinov IE,et al. Pulmonary atresia, ventricular septal defect, and major aortopulmonary collaterals:neonatal pulmonary artery rehabilitation without unifocalization. Ann Thorac Surg.2012;93(1):185-91.
[84]Davies B, Mussa S, Davies P,et al.Unifocalization of major aortopulmonary collateral arteries in pulmonary atresia with ventricular septal defect is essential to achieve excellent outcomes irrespective of native pulmonary artery morphology.J Thorac Cardiovasc Surg.2009; 138(6):1269-75.
[85]Marasini M, Gorrieri PF, Tuo G,et al.Long-term results of catheter-based treatment of pulmonary atresia and intact ventricular septum.Heart.2009;95(18): 1520-4.
[86]Li S, Chen W, Zhang Y,et al. Hybrid therapy for pulmonary atresia with intact ventricular septum. Ann Thorac Surg.2011;91(5):1467-71.
[87]Fenton KN, Pigula FA, Gandhi SK,et al.Interim mortality in pulmonary atresia with intact ventricular septum.Ann Thorac Surg.2004;78(6):1994-8.
[88]John AS, Warnes CA. Clinical outcomes of adult survivors of pulmonary atresia with intact ventricular septum.Int J Cardiol.2011.Epub ahead of print
[89]Rychik J, Levy H, Gaynor JW,et al. Outcome after operations for pulmonary atresia with intact ventricular septum J Thorac Cardiovasc Surg.1998; 116(6): 924-31.
[90]Ashburn DA, Blackstone EH, Wells WJ, et al. Determinants of mortality and type of repair in neonates with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg.2004; 127:1000-1007.
[91]Dyamenahalli U, McCrindle BW, McDonald C,et al. Pulmonary atresia with intact ventricular septum:management of,and outcomes for,a cohort of 210 consecutive patients. Cardiol Young.2004;14:299-308.
[92]Ekman Joelsson BM, Sunnegardh J, Hanseus K,et al.The outcome of children born with pulmonary atresia and intact ventricular septum in Sweden from 1980 to 1999. Scand Cardiovasc J.2001;35:192-198.
[93]Odim J, Laks H, Plunkett MD,et al.Successful management of patients with pulmonary atresia with intact ventricular septum using a three tier grading system for right ventricular hypoplasia.Ann Thorac Surg.2006; 81:678-684.
[94]Mair DD, Julsrud PR, Puga FJ,et al. The Fontan procedure for pulmonary atresia with intact ventricular septum:operative and late results. J Am Coll Cardiol.1997; 29:1359-64.
[95]Najm HK, Williams GW, Coles JG,et al.Pulmonary atresia with intact ventricular septum:results of the Fontan procedure.Ann Thorac Surg.1997;63:669-75.
[96]Hannan RL, Zabinsky JA, Stanfill RM,et al.Midterm results for collaborative treatment of pulmonary atresia with intact ventricular septum.Ann Thorac Surg.2009;87(4):1227-33.
[97]Daubeney PE, Wang D, Delany DJ,et al.Pulmonary atresia with intact ventricular septum:predictors of early and medium-term outcome in a population-based study J Thorac Cardiovasc Surg.2005;130:1071.
[98]Mishima A, Asano M, Sasaki S,et al. Long-term outcome for right heart function after biventricular repair of pulmonary atresia and intact ventricular septum.Jpn J Thorac Cardiovasc Surg.2000;48:145-152.
[99]Sanghavi DM, Flanagan M, Powell AJ,et al.Determinants of exercise function following univentricular versus biventricular repair for pulmonary atresia/intact ventricular septum. Am J Cardiol.2006;97:1638-1643.
[100]Ekman-Joelsson BM, Gustafsson PM, Sunnegardh J.Exercise performance after surgery for pulmonary atresia and intact ventricular septum.Pediatr Cardiol.2009; 30:752-762.
[101]Mi YP, Cheung YF.Assessment of right and left ventricular function by tissue Doppler echocardiography in patients after biventricular repair of pulmonary atresia with intact ventricular septum. Int J Cardiol.2006; 109:329-334.
[102]Numata S, Uemura H, Yagihara T,et al. Long-term functional results of the one and one half ventricular repair for the spectrum of patients with pulmonary atresia/stenosis with intact ventricular septum.Eur J Cardiothorac Surg.2003;24: 516-520.
[103]Pantely GA. Pulmonary atresia with ventricular septal defect.In:Gatzoulis MA, Swan L, Therrien J, et al. editor.Adult Congenital Heart Disease.Malden, MA: Blackwell;2005.p136.
[104]Cho JM, Puga FJ, Danielson GK,et al.Early and long-term results of the surgical treatment of tetralogy of Fallot with pulmonary atresia, with or without major aortopulmonary collateral arteries.J Thorac Cardiovasc Surg.2002; 124(1): 70-81.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |